Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
暂无分享，去创建一个
S. Peters | A. Santoro | K. Zaman | L. Paz-Ares | A. Awada | B. Besse | V. Moreno | A. Antón | R. López | V. Alfaro | C. Kahatt | V. Subbiah | V. Boni | R. Kristeleit | S. Chawla | J. Valdivia | J. Delord | V. Villalobos | Maite Martínez | J. Trigo | L. Wannesson | S. Ponce | J. Sarantopoulos | M. Rubio | M. E. Olmedo | J. Mosquera-Martínez | M. Sala | A. Zeaiter | J. Sands | J. Arrondeau | M. D'Arcangelo | C. Fernandez | Javier Gómez | M. Olmedo